Atlas Trials

A Dose-Finding Study of AG-348 in Sickle Cell Disease

Clinical trial NCT04000165 · COMPLETED

Trial details

NCT number
NCT04000165
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2019-07-11
Primary completion
2021-06-21
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.